DIN 02455889 — CORTIMENT 9 MG
CORTIMENT is a tablet (delayed- and extended-release) of Budesonide (Oral) marketed by FERRING INC. The full Budesonide (Oral) monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02455889
- Brand name
- CORTIMENT
- Active ingredient
- Budesonide (Oral)
- Strength
- 9 MG
- Dosage form
- TABLET (DELAYED- AND EXTENDED-RELEASE)
- Route
- ORAL
- Manufacturer
- FERRING INC
- Health Canada status
- MARKETED
- Drug class
- Locally-acting oral corticosteroid (ileal- or colonic-release glucocorticosteroid)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Budesonide (Oral) products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02483874 | BUDESONIDE | 3 MG | CAPSULE (SUSTAINED-RELEASE) | TILLOTTS PHARMA GMBH | DORMANT |
| 02229293 | ENTOCORT | 3 MG | CAPSULE (SUSTAINED-RELEASE) | TILLOTTS PHARMA GMBH | MARKETED |
| 02513854 | JORVEZA | 0.5 MG | TABLET (ORALLY-DISINTEGRATING) | AVIR PHARMA INC. | MARKETED |
| 02493675 | JORVEZA | 1 MG | TABLET (ORALLY-DISINTEGRATING) | AVIR PHARMA INC. | MARKETED |